0
828
Drug Maker, GlaxoSmithKline, Pays $750 Million Over Alleged Violations
GlaxoSmithKline (GSK) reached a settlement with the U.S. Attorney's Office over alleged manufacturing violations of government drug standards. According to Business Wire, GSK will pay $750 million in fraud charges. $600 million will go to settle the civil case against... Read more